Here are three insights:
1. Based on end-users, ASCs are likely to have more growth than hospital outpatient departments in the market.
2. Factors driving market growth include a higher number of glaucoma patients, a growing aging population, new devices surfacing in the market, more awareness on safety and less use of prescription eye drops.
3. Asia Pacific will likely increase at the highest CAGR due to a large glaucoma population and more residents using these devices.
More articles on healthcare:
4 things to know about the Agency for Healthcare Research & Quality’s ambulatory surgery safety program
6 key points on Olympia Surgery Center’s nurse navigator program
FDA ordered Endo Pharma to remove opioid painkiller Opana ER from market — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.